Home - Products - GPCR/G Protein - Antibacterial - SPI009

SPI009

CAS No. 1008671-41-7

SPI009 ( SPI 009 )

Catalog No. M10055 CAS No. 1008671-41-7

SPI009 is a novel antipersister compound active against P. aeruginosa.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

SPI009
Note

Research use only, not for human use.
Brief Description

SPI009 is a novel antipersister compound active against P. aeruginosa.
Description

SPI009 is a novel antipersister compound active against P. aeruginosa; reduces the number of persisters up to 100,000-fold in both lab strains and clinical isolates of P. aeruginosa when combined with distinct classes of antibiotics; efficiently kills persister cells with minor cytotoxicity, and causes no erythrocyte damage.
Synonyms

SPI 009
Pathway

GPCR/G Protein
Target

Antibacterial
Recptor

Antibacterial
Research Area

——
Indication

——

Chemical Information

CAS Number

1008671-41-7
Formula Weight

340.24
Molecular Formula

C17H19Cl2NO2
Purity

>98% (HPLC)
Solubility

——
SMILES

C1=CC=C(C=C1)OCC(CNCCC2=C(C=C(C=C2)Cl)Cl)O
Chemical Name

1-[(2,4-dichlorophenethyl)amino]-3-phenoxypropan-2-ol

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00836-17.
2. Defraine V, et al. Front Microbiol. 2017 Dec 22;8:2585.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

D-3-Phenyllactic aci...

D-3-Phenyllactic acid is an anti-bacterial agent excreted by Geotrichum candidum inhibits a range of Gram-positive from humans and foodstuffs and Gram-negative bacteria found in humans.
Eperezolid

An oxazolidinone antibiotic that possesses potent antimicrobial activity in vitro and in vivo.
TBA-354

TBA-354 is a novel antitubercular agent that shows MIC of 6 uM against M. tuberculosis H37Rv.

Sign In Join Free